| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) | 
|---|
| 03/27/2014 | WO2011163029A3 Alkenyl substituted cycloaliphatic compounds as chemical inducers of proximity | 
| 03/27/2014 | WO2010129671A3 Method of and apparatus for changing one type of cell into another type of cell | 
| 03/27/2014 | US20140090116 Fad2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks | 
| 03/27/2014 | US20140090115 Functional expression of shuffled yeast nitrate transporter (ynt1) in maize to improve nitrate uptake under low nitrate environment | 
| 03/27/2014 | US20140090114 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement | 
| 03/27/2014 | US20140090113 Engineered transgene integration platform (etip) for gene targeting and trait stacking | 
| 03/27/2014 | US20140090112 Fad2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks | 
| 03/27/2014 | US20140090110 Plants having enhanced yield-related traits and method for making the same | 
| 03/27/2014 | US20140090109 Cultivar, method for differentiating plant cultivars, and method for causing earlier maturing of rice individual | 
| 03/27/2014 | US20140090108 Vectors and Methods For Enhancing Recombinant Protein Expression in Plants | 
| 03/27/2014 | US20140090107 Plant variant, method for producing plant variant, and method for accumulating soluble sugar | 
| 03/27/2014 | US20140090106 Lysm receptor-like kinases to improve plant defense response against fungal pathogens | 
| 03/27/2014 | US20140090105 Methods for Increasing Resistance to Soybean Cyst Nematode in Soybean Plants | 
| 03/27/2014 | US20140090104 Insecticidal proteins | 
| 03/27/2014 | US20140090103 Methods and compositions for increasing plant disease resistance and yield | 
| 03/27/2014 | US20140090102 Use of the rd29 promoter or fragments thereof for stress-inducible expression of transgenes in cotton | 
| 03/27/2014 | US20140090101 Transgenic plants with enhanced agronomic traits | 
| 03/27/2014 | US20140090098 Methods and compositions for extending shelf life of plant products | 
| 03/27/2014 | US20140090094 Modulators of slc22a7 | 
| 03/27/2014 | US20140088300 Modified siRNA Molecules Incorporating 5-Fluoro-2'-Deoxyuridine Residues to Enhance Cytotoxicity | 
| 03/27/2014 | US20140088180 Subgroup b recombinant human adenovirus vector, and methods for constructing and for using the same | 
| 03/27/2014 | US20140088177 Recombinant vsv for the treatment of tumor cells | 
| 03/27/2014 | US20140088176 Gene transfer for regulating smooth muscle tone | 
| 03/27/2014 | US20140088175 Transduction of cells by adeno-associated virus vectors | 
| 03/27/2014 | US20140088174 Compounds and methods for altering activin receptor-like kinase signaling | 
| 03/27/2014 | US20140088173 Aging marker, method for evaluating aging inhibitor, and cancer inhibitor | 
| 03/27/2014 | US20140088172 RNAi-Mediated Inhibition of Histamine Receptor H1-Related Conditions | 
| 03/27/2014 | US20140088170 Differentially expressed microrna molecules for the treatment and diagnosis of cancer | 
| 03/27/2014 | US20140087972 Method of immobilising rna onto a surface | 
| 03/27/2014 | US20140087970 Serine biosynthesis pathway inhibition for treatment of cancer | 
| 03/27/2014 | US20140087470 Reversible immortalization | 
| 03/27/2014 | US20140087469 System and process for genetic and epigenetic treatment | 
| 03/27/2014 | US20140087468 Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters | 
| 03/27/2014 | US20140087444 Proviral Plasmids and Production of Recombinant Adeno-Associated Virus | 
| 03/27/2014 | US20140087436 Autotrophic hydrogen bacteria and uses thereof | 
| 03/27/2014 | US20140087426 Transcription activator-like effector nucleases (talens) | 
| 03/27/2014 | US20140087422 Nucleic acids related to fusion proteins | 
| 03/27/2014 | US20140087393 Methods for predicting pregnancy outcome in a subject by hcg assay | 
| 03/27/2014 | US20140087384 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues | 
| 03/27/2014 | US20140087374 The Use of Microfluidic Systems in the Electrochemical Detection of Target Analytes | 
| 03/27/2014 | US20140087370 Sample treatment device, sample treatment method, and reaction container for use therein | 
| 03/27/2014 | US20140086959 Method for producing milk having an immunoregulatory action | 
| 03/27/2014 | US20140086944 DNA VACCINE CONTAINING SPECIFIC EPITOPE OF APOLIPOPROTEIN (a) | 
| 03/27/2014 | US20140086935 Human TIMP-1 Antibodies | 
| 03/27/2014 | US20140086914 TREATMENT METHODS USING c-MET ANTIBODIES | 
| 03/27/2014 | US20140086887 Adult stem cell line introduced with hepatocyte growth factor gene and neurogenic transcription factor gene with basic helix-loop-helix motif and uses thereof | 
| 03/27/2014 | US20140086885 Methods and compositions for targeted cleavage and recombination | 
| 03/27/2014 | US20140086849 Naturally-Occurring CpG Oligonucleotide Compositions and Therapeutic Applications Thereof | 
| 03/27/2014 | DE102011080853B4 Verfahren zur Isolierung von RNA aus Volblutproben A process for the isolation of RNA from Volblutproben | 
| 03/26/2014 | EP2711704A1 Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and egfr inhibitor | 
| 03/26/2014 | EP2711433A1 Method for predicting effectiveness of angiogenesis inhibitor | 
| 03/26/2014 | EP2711428A1 Site-specific integration | 
| 03/26/2014 | EP2711427A1 HCV gene | 
| 03/26/2014 | EP2711426A1 Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences | 
| 03/26/2014 | EP2711425A1 Plants having enhanced yield-related traits and a method for making the same | 
| 03/26/2014 | EP2711424A2 Plants having enhanced yield-related traits and a method for making the same | 
| 03/26/2014 | EP2711423A1 Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing and/or for hydrating skin | 
| 03/26/2014 | EP2711422A1 Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing and/or for hydrating skin | 
| 03/26/2014 | EP2711421A1 Method for separating and purifying rna from biomaterial | 
| 03/26/2014 | EP2711420A1 Method of selectively driving gene expression in anaerobic tissue by alcohol dehydrogenase promoter and uses thereof | 
| 03/26/2014 | EP2711377A1 Fusion protein for antagonizing angiogenesis inducible factors and uses thereof | 
| 03/26/2014 | EP2711376A1 Fgfr-fc fusion protein and use thereof | 
| 03/26/2014 | EP2711023A1 Osteogenesis promoter | 
| 03/26/2014 | EP2711017A1 Immunity inducing agent | 
| 03/26/2014 | EP2710153A1 Detection of saxitoxin-producing dinoflagellates | 
| 03/26/2014 | EP2710130A1 Highly inducible dual-promoter lentiviral tet-on system | 
| 03/26/2014 | EP2710129A1 Therapeutic fusion proteins | 
| 03/26/2014 | EP2710128A1 Plants having enhanced abiotic stress resistance | 
| 03/26/2014 | EP2710125A1 Methods for improving and managing nucleoside reverse-transcriptase inhibition based treatment | 
| 03/26/2014 | EP2710117A2 Recombinant microorganisms and methods of use thereof | 
| 03/26/2014 | EP2710114A2 High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris | 
| 03/26/2014 | EP2710042A2 Multi-specific fab fusion proteins and methods of use | 
| 03/26/2014 | EP2710039A2 Anti-cgrp compositions and use thereof | 
| 03/26/2014 | EP2709664A1 Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof | 
| 03/26/2014 | EP2709653A2 Aav mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity | 
| 03/26/2014 | EP2709445A1 Porcine reproductive and respiratory syndrome virus resistant animals | 
| 03/26/2014 | EP2709441A1 Plants having one or more enhanced yield- related traits and method for making the same | 
| 03/26/2014 | EP2535358A9 Radioactive metal-labeled anti-cadherin antibody | 
| 03/26/2014 | CN1901795B Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms | 
| 03/26/2014 | CN103687963A A method of determining the prognosis of hepatocellular carcinomas using a multigene signature associated with metastasis | 
| 03/26/2014 | CN103687952A Down regulating gene expression in insect pests | 
| 03/26/2014 | CN103687951A Plants resistant to insect pests | 
| 03/26/2014 | CN103687950A Plant regulatory elements and uses thereof | 
| 03/26/2014 | CN103687949A Virus resistant transgenic silkworm | 
| 03/26/2014 | CN103687948A Method for identifying antibiotic targets | 
| 03/26/2014 | CN103687947A Mutant beta-glucosidase, enzyme composition for decomposing biomass, and method for producing sugar solution | 
| 03/26/2014 | CN103687946A Peptide for inducing regeneration of tissue and use thereof | 
| 03/26/2014 | CN103687945A Anti-B7-H3 antibody | 
| 03/26/2014 | CN103687943A Dna polymerases with improved activity | 
| 03/26/2014 | CN103687942A Virus-like particles and process for preparing same | 
| 03/26/2014 | CN103687880A Amphipathic peptide-lipase conjugate having advanced lipase activity and use thereof | 
| 03/26/2014 | CN103687873A Identifying affinity-matured human antibodies | 
| 03/26/2014 | CN103687869A HCV genotype 3 replicons | 
| 03/26/2014 | CN103687868A Hcv genotype 4 replicons | 
| 03/26/2014 | CN103687625A Cross-protective arenavirus vaccines and their method of use | 
| 03/26/2014 | CN103687620A Compositions for inhibiting masp-2 dependent complement acitivation | 
| 03/26/2014 | CN103687615A Canine coronavirus vaccine | 
| 03/26/2014 | CN103687614A Foot and mouth disease virus recombinant vaccines and uses thereof | 
| 03/26/2014 | CN103687482A Porcine reproductive and respiratory syndrome virus resistant animals | 
| 03/26/2014 | CN103687480A Tobacco inbred plants NCBEX1F, NCBEX1MS, and NC EX90 |